Theme 2012 Project Proposal Preparationgs 1302266573
Theme 2012 Project Proposal Preparationgs 1302266573
Theme 2012 Project Proposal Preparationgs 1302266573
7. dubna 2011
! ! ! !
!
Page limits: remember to keep to the page limits as specified Minimum font size allowed: 11 points Page size: A4, all margins should be at least 15 mm (excluding any footers or headers) Clearly readable text (e.g. Arial or Times New Roman) Maximum of 50006000 possible characters per page (including spaces)
The Commission will instruct the experts to disregard any excess pages.
3
List of participants: List as many of the expected members of your consortium as possible At least minimum number of participants needed to satisfy eligibility conditions must be named
Table of Contents Note: The cover page, the above tables, and the table of contents do not count toward the page limits specified.
1.2 Progress beyond the state-of-the-art Describe the state-of-the-art in area concerned Focus on advance that the project proposed would bring about If applicable, refer to results of any patent search you might have carried out 1.3 S/T methodology and associated work plan Present just an overview 2. Implementation This section is not evaluated in Stage 1
11
12
List of participants: Use the same participant numbering as in section A2 of administrative forms
Czech Republic
14
Table of Contents Note: The cover page, the above tables, and the table of contents do not count toward the page limits specified.
15
Proposal 1. Scientific and/or technical quality, relevant to the topics addressed by the call 1.1 Concept and objectives Explain concept of your project What are main ideas leading you to propose this work? Describe in detail S&T objectives Show how they relate to the topics addressed by the call Objectives achievable within the project, not through subsequent development Objectives stated in measurable and verifiable form (milestones)
16
Present your plans as follows: 1. Overall strategy of the work plan (max.1 page) 2. Timing of different WPs and their components (e.g. Gantt chart) 3. Detailed work description broken down into WPs Work package list (table 1.3a) Deliverables list (table 1.3b) List of milestones (table 1.3c) Description of each WP (table 1.3d) Summary effort table (table 1.3e) 4. Graphical presentation of the components showing their interdependencies (e.g. Pert diagram) 5. Any significant risks, and associated contingency plans
18
WP1
Model development
RTD
RTD = Research and technological development; DEM = Demonstration; MGT = Management of the consortium; OTHER = Other specific activities (preparation for dissemination and/or exploitation of project results, coordination)
19
1.1
Polymer. processes
RE
month 8
R = Report, P = Prototype, D = Demonstrator, O = Other, PU = Public PP = Restricted to other programme participants, RE = Restricted to group specified by consortium, CO = Confidential (only for consortium members)
20
Table 1.3c: List of milestones Milestones control points where decisions are needed with regard to next stage of the project Example: When the consortium must decide which of several technologies to adopt for further development
M1
Model in operation
month 8
21
RTD
RTD = Research and technological development DEM = Demonstration MGT = Management of consortium OTHER = Other specific activities (e.g. to prepare for dissemination and/or exploitation of project results, coordination)
22
23
Table 1.3e: Summary of staff effort Useful for evaluators Indicate number of person months over the whole duration of work, for each WP, for each participant Identify WP-leader for each WP by showing relevant personmonth figure in bold
VSCHT
12,5
15,5
24
2. Implementation 2.1 Management structure and procedures (max. 5 pages) Describe organisational structure and decision-making mechanisms of the project Show how they match complexity and scale of the project 2.2 Individual participants (1 page per participant) For each participant, provide: Brief description of legal entity Main tasks they have been attributed Previous experience relevant to the tasks Short profile of staff members who will undertake the work
25
2.3 Consortium as a whole (No page limit) Describe and explain: How participants collectively constitute consortium capable of achieving objectives How they are suited and committed to the tasks Show complementarity between the participants How the consortium is well-balanced in relation to objectives Industrial/commercial involvement to ensure exploitation of results How the opportunity of involving SMEs has been addressed
26
i) Sub-contracting: If any part of the work is to be sub-contracted by the participant responsible for it. Describe the work and explain why sub-contract approach ii) Other countries: If one or more of participants is based in country outside the EU, and it is not Associated Country, and it is not International Cooperation Partner Country. Explain in terms of objectives why such funding is essential iii) Additional partners: If there are as-yet-unidentified participants, their role and integration into running project should be described. Not counted in min. number of participants regarding eligibility of proposal!
27
2.4 Resources to be committed (max. 2 pages) Describe how total of necessary resources will be mobilised (including any resources complementing EC contribution) Show how overall financial plan for the project is adequate
28
3. Impact 3.1 Expected impacts listed in the work programme Describe how your project will contribute towards the expected impacts in relation to topics in question Mention steps needed to bring about these impacts Explain why contribution requires a European approach Indicate how account is taken of other national or international research activities Mention any assumptions and external factors determining whether impacts will be achieved
29
Use of animals: Application of the 3Rs (Replace, Reduce, Refine) must be addressed Numbers of animals should be specified Describe what happens to animals after the research experiments The use of animals requires permits and/or authorizations from national competent authorities
32
Human embryonic stem cells: Proposals have to address: That the research work aims to advance scientific knowledge in basic research or to increase medical knowledge for development of diagnostic, preventive or therapeutic methods to be applied to humans Necessity to use hESC in order to achieve scientific objectives set forth in the proposal
Example: Document that appropriate validated alternatives (stem cells from other sources or origins) are not suitable and/or available to achieve expected goals of the proposal.
33
Human embryonic stem cells: Take into account legislation, regulations, ethics rules and/or codes of conduct in country where the research using hESC is to take place Including procedures for obtaining informed consent. Ensure that for all hESC lines to be used in the project were derived from embryo's of specific character
Dedicated website that aims to provide clear, helpful information on ethics issues is available at: http://cordis.europa.eu/fp7/ethics_en.html
34
Gabriela Salejova
7. dubna 2011
Czech Republic NMP NCP European Project Manager TC ASCR Email: salejova@tc.cz Mobile: +420 724 353 611
www.tc.cz